E | HR | 95% CI | P | F | HR | 95% CI | P |
---|
NGT (OGTT) | ref | ref | ref | | NGT (OGTT) | ref | ref | ref | |
IFG/IGT (OGTT) | 0.79 | 0.47 | 1.34 | NS | IFG/IGT (OGTT) | 0.91 | 0.41 | 1.99 | NS |
New T2DM (OGTT) | 1.15 | 0.65 | 2.07 | NS | New T2DM (OGTT) | 1.93 | 0.90 | 4.12 | NS |
Known T2DM | 0.78 | 0.28 | 2.21 | NS | Known T2DM | 0.47 | 0.06 | 3.54 | NS |
Women | ref | ref | ref | | |
Men | 0.85 | 0.49 | 1.47 | NS |
NSTEMI | ref | ref | ref | |
STEMI | 0.85 | 0.54 | 1.33 | NS |
- MACE major adverse cardiovascular event, HR hazard ratio, NGT normal glucose tolerance test, IFG/IGT impaired fasting glucose/impaired glucose tolerance, New T2DM newly detected type 2 diabetes mellitus, Known T2DM known type 2 diabetes mellitus, OGTT oral glucose tolerance test, NSTEMI non-ST-segment elevation myocardial infarction, STEMI ST-segment elevation myocardial infarction, NS not significant, ref reference